Which statement about human milk versus standard formula in CF infants is true?

Which statement about human milk versus standard formula in CF infants is true?

• A. Human milk has immunologic properties, growth factors, and pre-/probiotics
• B. Human milk always leads to better weight gain than formula
• C. Standard formula is superior for enzyme dosing
• D. There is no difference between them in CF infants

Answer: (A)

In CF infants, human milk brings bioactive components that standard formula does not replicate: immunologic substances, growth-promoting factors, and prebiotic elements that help shape the gut microbiome and support intestinal maturation. These immunologic components, such as secretory IgA, lactoferrin, and other immune-modulating proteins, help defend the gut against infections. Growth factors and hormones in milk promote the maturation and integrity of the intestinal lining, which can be particularly beneficial when fat malabsorption and pancreatic insufficiency are present in CF. The oligosaccharides in human milk act as prebiotics, fostering beneficial bacteria and a healthier gut environment, which can influence digestion and nutrient utilization. Because of these bioactive and protective features, human milk offers advantages that standard formula simply cannot match. That said, weight gain in CF infants depends on multiple factors, including energy density, fat absorption, and enzyme dosing; human milk is not guaranteed to produce superior weight gain in every case, and formulas can be fortified or adjusted to meet high-energy needs when necessary. Still, the fundamental point is that the immunologic, growth-promoting, and prebiotic components of human milk give it distinct advantages over standard formula in CF infants.

In CF infants, human milk brings bioactive components that standard formula does not replicate: immunologic substances, growth-promoting factors, and prebiotic elements that help shape the gut microbiome and support intestinal maturation. These immunologic components, such as secretory IgA, lactoferrin, and other immune-modulating proteins, help defend the gut against infections. Growth factors and hormones in milk promote the maturation and integrity of the intestinal lining, which can be particularly beneficial when fat malabsorption and pancreatic insufficiency are present in CF. The oligosaccharides in human milk act as prebiotics, fostering beneficial bacteria and a healthier gut environment, which can influence digestion and nutrient utilization.

Because of these bioactive and protective features, human milk offers advantages that standard formula simply cannot match. That said, weight gain in CF infants depends on multiple factors, including energy density, fat absorption, and enzyme dosing; human milk is not guaranteed to produce superior weight gain in every case, and formulas can be fortified or adjusted to meet high-energy needs when necessary. Still, the fundamental point is that the immunologic, growth-promoting, and prebiotic components of human milk give it distinct advantages over standard formula in CF infants.